[The family doctor and the barriers to prescribing the new oral anticoagulants: Heterogeneity, inequality and confusion. Statement of the Spanish Primary Care and Family Medicine Societies].

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. [Prevalence of oral anticoagulation and quality of its management in primary healthcare: A study by the Health Sentinel Network of the Region of Valencia (Spain)].Atencion primaria · 2017
   Observational
2. [Conflicts of interest and need for transparency: in light of consensus on prescribing of new oral anticoagulants].Atencion primaria · 2015
   Article
3. [Positioning of scientific societies and working groups reviews: statement on conflicts of interest and need for transparency].Atencion primaria
   Article
4. [Author's reply].Atencion primaria
   Article

Corrections and comments

• Commented on by
  [Positioning of scientific societies and working groups reviews: statement on conflicts of interest and need for transparency].
• Commented on by
  [Author's reply].

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as